Volume 5, Supplement 3SupplementE-1899: An Eastern Cooperative Oncology Group Study Comparing Ketoconazole Plus Hydrocortisone with Docetaxel Plus Estramustine for Asymptomatic, Androgen-Independent, Nonmetastatic Prostate Cancer...Michael CarducciRobert DreicerProstate cancerDocetaxelEstramustineKetoconazole
Volume 5, Supplement 3SupplementRationale for the Radiation Therapy Oncology Group Study RTOG P-0014Kenneth J PientaHoward M SandlerProstate cancerChemotherapyAndrogen ablationClinical trialsHormone-refractory disease
Volume 5, Supplement 3SupplementA New Formulation of Calcitriol (DN-101) for High-Dose Pulse Administration in Prostate Cancer TherapyTomasz M BeerWilliam David HennerHypercalcemiaCalcitriolAndrogen-independent prostate cancerHigh-dose
Volume 5, Supplement 3SupplementNeoadjuvant Therapy for Prostate Cancer: An Oncologist's PerspectiveMaha HA HussainElizabeth C KentProstate cancerChemotherapyRadical prostatectomyRadiotherapyHormonal therapyNeoadjuvant therapy
Volume 5, Supplement 3SupplementInitial Experience with Single-Agent Docetaxel as Neoadjuvant Therapy in Men with Locally Advanced Prostate CancerRobert DreicerEric A KleinLocally advanced prostate cancerRadical prostatectomyNeoadjuvant
Volume 5, Supplement 3SupplementDocetaxel for the Treatment of Hormone-Refractory Prostate CancerDaniel P PetrylakChemotherapyProstate-specific antigenDocetaxelHormone-refractory prostate cancerMicrotubule
Volume 5, Supplement 3SupplementBiochemical (Prostate-Specific Antigen) Relapse: An Oncologist's PerspectiveMary-Ellen TaplinProstate cancerProstate-specific antigenAdjuvantBiochemical relapse
Volume 5, Supplement 1SupplementDecreased Testosterone in the Aging Male: Summary and ConclusionsJacob Rajfer